Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
Supply shortages have complicated the pharmaceutical industry. Eli Lilly & Co are making the right pivots. New partnerships aimed at … Read more
Supply shortages have complicated the pharmaceutical industry. Eli Lilly & Co are making the right pivots. New partnerships aimed at … Read more
Following is the unofficial transcript of a CNBC exclusive interview with Novartis (NYSE:NVS) CEO Dr. Vas Narasimhan on CNBC’s “Squawk … Read more
Tech companies are generally known to be very innovative as they keep coming up with new products and features on … Read more